Short-Term Application of Tocilizumab Following Myocardial Infarction

NCT02419937 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

FED

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Tocilizumab
DRUG: Placebo

Sponsor

Keesler Air Force Base Medical Center